Latest filing published 01 Oct 2025 for Drugs Made In America Acquisition II Corp..
No signal scores available.
Not enough history yet: 0 closed purchases, at least 2 are needed.
Filings by Lynn Stockwell span 3 companies, the busiest being Bright Green Corp, Drugs Made In America Acquisition Corp. and Drugs Made In America Acquisition II Corp. The record holds 15 filings, for trades running from 6 February 2023 to 26 September 2025.
Market trades split into 3 purchases and 4 sales (€438k). No amount is published for 5 filings, which the totals therefore leave out. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. 2025 to date brings 3 purchases and 2 sales.
The record was last updated on 1 October 2025 with a transaction in Drugs Made In America Acquisition II Corp. The latest purchase dates back some time: it was published 388 days ago, on 1 October 2025. Typically, a trade is published a median of 6 days after it takes place. For comparison, the SEC allows two business days to file a Form 4. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
15 of 15 declarations